Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Kaiser Permanente
Duke University
University of Colorado, Denver
Unity Health Toronto
Colorado State University
Institut du Cancer de Montpellier - Val d'Aurelle
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
New Mexico Cancer Research Alliance
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Stanford University
Universitat Jaume I
Stanford University
Universidade Federal de Pernambuco
Washington University School of Medicine
Milton S. Hershey Medical Center
Dublin City University
University Hospital, Ghent
Blue Note Therapeutics
Roswell Park Cancer Institute
State Scientific Centre of Coloproctology, Russian Federation
Albert Einstein College of Medicine
City of Hope Medical Center
Beth Israel Medical Center
Luxembourg Institute of Health
Ohio State University Comprehensive Cancer Center
Johns Hopkins Bloomberg School of Public Health
National Cancer Institute (NCI)
University of Washington
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
University of Utah
Dartmouth-Hitchcock Medical Center